Sitemap
November 04, 2009 Articles
Filter by Available Specialty
- Allergan announces Horizon Grant recipients for clinical research in ophthalmology
- CDC: Demand high for H1N1 vaccine, seasonal influenza vaccine
- EyeGate Pharma completes phase 2 study of transscleral drug delivery system
- FDA orthopedic panel: PMA application for spine stabilization system ‘not approvable’
- Future physician workforce projected to decrease
- NCCN updates renal cell carcinoma guidelines
- Olmesartan medoxomil delayed microalbuminuria in patients with type 2 diabetes
- Pareto was right. Again.
- Promedior receives European orphan drug designation for PRM-151
- Radical stereotactic radiosurgery effective in inoperable early stage NSCLC
- Updated ACC/AHA guidelines urge consideration of patient risk-benefit ratio for perioperative beta-blocker administration